Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Pathophysiology, Diagnosis, and New and Emerging Treatment Options
FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG): Patient Selection, Tailoring Dosing Regimens, Updated Disease Management Paradigms
Early, Optimal Management of CKD and Cardiorenal Disease to Prevent Disease Progression and Improve Outcomes
Hypertrophic Cardiomyopathy: New Evidence, Updated Guidelines to Support Optimal Management
Journal Club: The 2023 WHF Consensus Document on ATTR-CM
Code ICH: A Call to Action
Notable Highlights “LIVE” from ACC24: Advances in Non-Statin Lipid Therapy
Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer
Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies
CAR T Research and Treatment Advances in Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL) and Follicular Cell Lymphoma (FL) Therapies
